Cipher Pharmaceuticals Inc.
CPHRF
$7.66
-$0.19-2.42%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -90.55% | -39.16% | -35.69% | 8.87% | 128.95% |
| Total Depreciation and Amortization | 559.25% | 1.04% | 5.86% | 1.49% | -21.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.82% | 110.16% | -241.20% | 123.43% | -1,194.07% |
| Change in Net Operating Assets | -108.77% | 266.84% | 73.01% | -422.83% | 1,008.88% |
| Cash from Operations | -67.84% | 155.75% | 0.75% | -59.54% | 102.68% |
| Capital Expenditure | -727,354.55% | -83.33% | 71.43% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -727,354.55% | -83.33% | 95.83% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -265.52% | -3.57% | 22.22% | -24.14% | -38.10% |
| Issuance of Common Stock | -58.33% | -76.70% | -47.45% | 46.27% | 306.06% |
| Repurchase of Common Stock | -- | 100.00% | 96.55% | -3,764.39% | 48.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 790,220.00% | 95.05% | 97.96% | -18,200.00% | 88.84% |
| Foreign Exchange rate Adjustments | 125.24% | -20.47% | -141.91% | 308.16% | -194.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -740.68% | 178.43% | 195.36% | -139.34% | 97.46% |
